O2MEDi
Latest round
- Seed
Last raised
- Nov 2021
Total raised
- Undisclosed
Investors
- 2
About O2MEDi
Founded in 2020 and based in Ulsan, South Korea, O2MEDi Inc.O2MEDi Inc. specializes in innovative treatments utilizing photodynamic therapy technology. Founded in Ulsan, South Korea in 2020, the company has conducted one deal as of November 2021.O2MEDi specializes in the development of innovative photodynamic therapy (PDT) products aimed at treating challenging diseases, particularly resistant cancers such as pancreatic cancer. Their core technology employs iridium-based photosensitizers designed to generate reactive oxygen species (ROS) when activated by light, facilitating the targeted destruction of cancer cells that exhibit drug resistance. This technology overcomes the limitations of existing treatments, particularly in hypoxic environments where traditional methods are less effective. O2MEDi’s solutions are designed for healthcare professionals and institutions, with ongoing clinical trials and preclinical studies to validate their efficacy in treating various cancers.O2MEDi generates revenue through partnerships with research institutions and healthcare providers, focusing primarily on the preclinical and clinical stages of their product pipeline. Business transactions typically involve collaborative agreements for clinical trials and the development of therapeutic agents, with potential revenue streams derived from licensing agreements and product commercialization in the future. Their flagship technology addresses the specific needs of oncologists dealing with treatment-resistant cancers, positioning them favorably for future market penetration.In November 2021, O2MEDi Inc. The company plans to expand its market reach beyond South Korea into international markets, with a timeline yet to be specified. Their strategy includes advancing clinical trials and securing necessary regulatory approvals to facilitate these expansion efforts.
Who invested in O2MEDi
2 investors across 1 round
See all investors in O2MEDi
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 16, 2021
Amount
Undisclosed
Investors
Questions about O2MEDi
Who invested in O2MEDi?
O2MEDi has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has O2MEDi raised?
O2MEDi has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did O2MEDi last raise money?
O2MEDi's most recent round on record is a Seed, in Nov 2021.
What does O2MEDi do?
Founded in 2020 and based in Ulsan, South Korea, O2MEDi Inc.
Where is O2MEDi headquartered?
O2MEDi is headquartered in Ulsan, South Korea.
Which VCs invest in companies like O2MEDi?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at O2MEDi's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like O2MEDi? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.